General Ultrasound in Maryland

Sonavex develops automated 3D ultrasound solutions for dialysis access care, enabling quantification and visualization of critical clinical data. The company specializes in vascular assessment and cannulation guidance for arteriovenous fistula management. Primary product lines include EchoSure, which automatically measures volumetric flow rate, diameter, and depth of blood vessels; EchoMark, a patented ultrasound marker designed specifically for blood vessel visualization and tracking; and EchoMap, an intuitive vessel mapping system supporting cannulation procedures. These solutions are designed for point-of-care use across multiple clinical settings. The company is led by a multidisciplinary team including physicians, scientists, and technologists focused on delivering clinical and economic value to patients and health systems. Sonavex's technology addresses critical gaps in dialysis vascular access management, where accurate vessel assessment and maturation monitoring are essential for patient outcomes. The company has gained recognition in medical technology media and maintains a physician-supported, patient-oriented development approach.

CoapTech manufactures the PUMA-G System, the FDA-cleared ultrasound-guided percutaneous gastrostomy (PUG) solution for bedside feeding tube placement in critical care and acute care settings. The system enables physicians and advanced practice providers to perform gastrostomy procedures at the patient bedside using ultrasound visualization, eliminating the need for operating room scheduling, endoscopic reprocessing, or fluoroscopy exposure. Clinical evidence demonstrates significant hospital cost reductions (up to $34,778 per patient) and shortened ICU length of stay (5–10 days) compared to traditional PEG or PRG procedures. The PUMA-G System is deployed in ICUs, step-down units, floor units, interventional radiology suites, and long-term acute care hospitals. The system reduces procedural risks including organ perforation from blind sticks, infection from endoscope reprocessing, and radiation exposure from fluoroscopy. Key clinical applications include COVID-19 patient care (tandem tracheostomy–gastrostomy procedures) and integration into critical care teams to optimize patient throughput and procedural efficiency. CoapTech holds FDA 510(k) clearance and serves tertiary care centers, academic medical centers, community hospitals, and for-profit hospital systems across the United States.